{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:16:17Z","timestamp":1787807777847,"version":"build-2784847793"},"reference-count":79,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.antiviral.2013.09.030","type":"journal-article","created":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T04:24:01Z","timestamp":1383279841000},"page":"S39-S47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"S","title":["Multipurpose prevention technologies: Products in development"],"prefix":"10.1016","volume":"100","author":[{"given":"David R.","family":"Friend","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin T.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick F.","family":"Kiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith R.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2013.09.030_b0005","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women","volume":"329","author":"Abdool Karim","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2013.09.030_b0010","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/COH.0b013e328358b9ce","article-title":"Next-generation oral preexposure prophylaxis: beyond tenofovir","volume":"7","author":"Abraham","year":"2012","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.antiviral.2013.09.030_b0015","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.chom.2011.08.015","article-title":"Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication","volume":"10","author":"Andrei","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2013.09.030_b0020","unstructured":"Andrews, C., Gettie, A., Russell-Lodrique, K., Moss, L., Mohri, H., Spreen, W., Cheng-Mayer, C., Hong, Z., Markowitz, M., Ho, D., 2013. Long-acting parenterial formulation of GSK1265744 protects macaques against repeated intrarectal challenges with SHIV. In: 20th Conference on Retroviruses and Opportunistic Infections, Atlanta, GA, 24LB."},{"key":"10.1016\/j.antiviral.2013.09.030_b0025","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejpb.2009.03.006","article-title":"Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment","volume":"72","author":"Baert","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.antiviral.2013.09.030_b0030","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1586\/17434440.5.5.639","article-title":"Contraceptive devices: intravaginal and intrauterine delivery systems","volume":"5","author":"Benagiano","year":"2008","journal-title":"Expert Rev. Med. Devices"},{"key":"10.1016\/j.antiviral.2013.09.030_b0035","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0968-8080(06)28262-4","article-title":"Dual protection: more needed than practised or understood","volume":"14","author":"Berer","year":"2006","journal-title":"Reprod. Health Matters"},{"key":"10.1016\/j.antiviral.2013.09.030_b0040","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0039-128X(00)00175-6","article-title":"Progestin \u2013 only contraceptive rings","volume":"65","author":"Brache","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.antiviral.2013.09.030_b0045","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.contraception.2008.08.010","article-title":"Effect of sexual intercourse on the absorption of levonorgestrel after vaginal administration of 0.75mg in Carraguard gel: a randomized, cross-over, pharmacokinetic study","volume":"79","author":"Brache","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.antiviral.2013.09.030_b0050","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.contraception.2007.04.005","article-title":"Effect of a single vaginal administration of levonorgestrel in Carraguard gel on the ovulatory process: a potential candidate for \u201cdual protection\u201d emergency contraception","volume":"76","author":"Brache","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.antiviral.2013.09.030_b0055","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.contraception.2010.04.012","article-title":"Contraceptive vaginal rings: a review","volume":"82","author":"Brache","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.antiviral.2013.09.030_b0060","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.contraception.2012.08.037","article-title":"Current status of contraceptive vaginal rings","volume":"87","author":"Brache","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.antiviral.2013.09.030_b0065","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0968-8080(03)02289-4","article-title":"Preventing sexually transmitted infections and unintended pregnancy, and safeguarding fertility: triple protection needs of young women","volume":"11","author":"Brady","year":"2003","journal-title":"Reprod. Health Matters"},{"key":"10.1016\/j.antiviral.2013.09.030_b0070","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0010-7824(79)90065-9","article-title":"Low-level, progestogen-releasing vaginal contraceptive devices","volume":"19","author":"Burton","year":"1979","journal-title":"Contraception"},{"key":"10.1016\/j.antiviral.2013.09.030_b0075","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0010-7824(78)90013-6","article-title":"Fabrication and testing of vaginal contraceptive devices designed for release of prespecified dose levels of steroids","volume":"17","author":"Burton","year":"1978","journal-title":"Contraception"},{"key":"10.1016\/j.antiviral.2013.09.030_b0080","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2307\/2135542","article-title":"Family planning, sexually transmitted diseases and contraceptive choice; a literature update \u2013 Part II","volume":"24","author":"Cates","year":"1992","journal-title":"Fam. Plann. Perspect."},{"key":"10.1016\/j.antiviral.2013.09.030_b0085","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/oxfordjournals.aje.a008744","article-title":"Contraception, unintended pregnancies, and sexually transmitted diseases: why isn\u2019t a simple solution possible?","volume":"143","author":"Cates","year":"1996","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.antiviral.2013.09.030_b0090","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00007435-199305000-00011","article-title":"Sexually transmitted diseases and family planning. Strange or natural bedfellows, revisited","volume":"20","author":"Cates","year":"1993","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.antiviral.2013.09.030_b0095","doi-asserted-by":"crossref","unstructured":"Clark, J.T., Shelke, N.B., Clark, M.R., Johnson, T.J., Smith, E.M., Andreasen, A.K., Nebeker, J.S., Fabian, J., McCabe, R.T., Friend, D.R., Kiser, P.F., 2013. Engineering a segmented dual-reservoir polyurethane intravaginal ring for simultaneous prevention of HIV transmission and unwanted pregnancy. PLoS One (submitted for publication).","DOI":"10.1371\/journal.pone.0088509"},{"key":"10.1016\/j.antiviral.2013.09.030_b0100","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.contraception.2008.07.001","article-title":"Comparative acceptability of the SILCS and ortho ALL-FLEX\u00ae diaphragms among couples in the Dominican Republic","volume":"78","author":"Coffey","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.antiviral.2013.09.030_b0105","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2307\/2991537","article-title":"The effectiveness of condoms in reducing heterosexual transmission of HIV","volume":"31","author":"Davis","year":"1999","journal-title":"Fam. Plann. Perspect."},{"issue":"Suppl. A","key":"10.1016\/j.antiviral.2013.09.030_b0400","first-page":"85","article-title":"The effectiveness of barrier methods of contraception in preventing the spread of HIV","volume":"9","author":"Feldblum","year":"1995","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2013.09.030_b0115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.contraception.2007.04.009","article-title":"Pregnancy among sex workers participating in a condom intervention trial highlights the need for dual protection","volume":"76","author":"Feldblum","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.antiviral.2013.09.030_b0120","doi-asserted-by":"crossref","first-page":"40433","DOI":"10.1074\/jbc.M111.289850","article-title":"Mechanism of HIV reverse transcriptase inhibition by zinc: formation of a highly stable enzyme\u2013(primer\u2013template) complex with profoundly diminished catalytic activity","volume":"286","author":"Fenstermacher","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2013.09.030_b0125","unstructured":"Fetherston, S.M., Boyd, P., Major, I., Devlin, B., Holt, J., Malcolm, R.K., 2013. Vaginal ring configurations for the simulaneous delivery of dapivirine and levonorgestrel. In: 40th Annual Meeting & Exposition of the Controlled Release Society, Honolulu, HI."},{"key":"10.1016\/j.antiviral.2013.09.030_b0130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/sti.75.1.3","article-title":"From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection","volume":"75","author":"Fleming","year":"1999","journal-title":"Sex. Transm. Infect."},{"key":"10.1016\/j.antiviral.2013.09.030_b0135","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1128\/AAC.01156-08","article-title":"Inhibition of human immunodeficiency virus type 1 infection by the candidate microbicide dapivirine, a nonnucleoside reverse transcriptase inhibitor","volume":"53","author":"Fletcher","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.09.030_b0140","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.contraception.2011.04.003","article-title":"Couples\u2019 acceptability of the SILCS diaphragm for microbicide delivery","volume":"85","author":"Frezieres","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.antiviral.2013.09.030_b0145","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s13346-011-0024-4","article-title":"Intravaginal rings: controlled release systems for contraception and prevention of transmission of sexually transmitted infections","volume":"1","author":"Friend","year":"2011","journal-title":"Drug Del. Transl. Res."},{"key":"10.1016\/j.antiviral.2013.09.030_b0150","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1517\/17425247.2012.668183","article-title":"Drug delivery in multiple indication (multipurpose) prevention technologies: systems to prevent HIV-1 transmission and unintended pregnancies or HSV-2 transmission","volume":"9","author":"Friend","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2013.09.030_b0155","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.antiviral.2010.09.005","article-title":"Combining prevention of HIV-1, other sexually transmitted infections and unintended pregnancies: development of dual-protection technologies","volume":"88","author":"Friend","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.09.030_b0160","first-page":"790154","article-title":"Developing multipurpose reproductive health technologies: an integrated strategy","volume":"2013","author":"Harrison","year":"2013","journal-title":"AIDS Res. Treat."},{"key":"10.1016\/j.antiviral.2013.09.030_b0165","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.contraception.2009.11.009","article-title":"Multipurpose prevention technologies for sexual and reproductive health: gaining momentum and promise","volume":"81","author":"Holt","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.antiviral.2013.09.030_b0170","doi-asserted-by":"crossref","first-page":"6272","DOI":"10.1128\/AAC.01431-12","article-title":"A 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxis","volume":"56","author":"Johnson","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.09.030_b0175","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejps.2009.11.007","article-title":"Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir","volume":"39","author":"Johnson","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.antiviral.2013.09.030_b0180","unstructured":"Kelly, L., Carr, D., Clark, M.R., Friend, D., Halliday, J., Livingstone, M., Ross, A., Salim, F., Trager, Laal, S., Wills, K., 2011. In vivo release in sheep of a dual loaded microbicide polyurethane vaginal ring. In: AAPS Annual Meeting and Exposition, T2258."},{"key":"10.1016\/j.antiviral.2013.09.030_b0185","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1128\/AAC.00796-13","article-title":"A modified zinc acetate gel, a potential nonantiretroviral microbicide, is safe and effective against simian-human immunodeficiency virus and herpes simplex virus 2 infection in vivo","volume":"57","author":"Kenney","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.09.030_b0190","first-page":"62","article-title":"State of the art in intravaginal ring technology for topical prophylaxis of HIV infection","volume":"14","author":"Kiser","year":"2012","journal-title":"AIDS Rev."},{"key":"10.1016\/j.antiviral.2013.09.030_b0195","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0010-7824(90)90141-H","article-title":"Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. I. Contraceptive efficacy and side effects. World Health Organization. Task force on long-acting systemic agents for fertility regulation","volume":"41","author":"Koetsawang","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.antiviral.2013.09.030_b0200","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0010-7824(90)90142-I","article-title":"Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. II. Expulsions and removals. World Health Organization. Task force on long-acting systemic agents for fertility regulation","volume":"41","author":"Koetsawang","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.antiviral.2013.09.030_b0205","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0010-7824(90)90143-J","article-title":"Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. III. The relationship between pregnancy rate and body weight. World Health Organization. Task force on long-acting systemic agents for fertility regulation","volume":"41","author":"Koetsawang","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.antiviral.2013.09.030_b0210","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.clinthera.2006.12.011","article-title":"The relation between intermittent dosing and adherence: preliminary insights","volume":"28","author":"Kruk","year":"2006","journal-title":"Clin. Ther."},{"key":"10.1016\/j.antiviral.2013.09.030_b0215","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0010-7824(82)90132-9","article-title":"Pharmacokinetic and pharmacodynamic investigations with vaginal devices releasing levonorgestrel at a constant, near zero order rate","volume":"26","author":"Landgren","year":"1982","journal-title":"Contraception"},{"key":"10.1016\/j.antiviral.2013.09.030_b0220","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.contraception.2010.06.006","article-title":"Effects of the levonorgestrel-releasing intrauterine system on cervical mucus quality and sperm penetrability","volume":"82","author":"Lewis","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.antiviral.2013.09.030_b0405","unstructured":"Livingstone, E., Carr, D., Clark, M.R., Friend, D., Halliday, J., Kelly, L., Ross, F., Salim, F., Trager, L., Wills, K., 2011. Development of a dual loaded microbicide polyurethane vaginal ring. In: American Association of Pharmaceutical Sciences Annual Meeting and Exposition Washington, DC."},{"key":"10.1016\/j.antiviral.2013.09.030_b0230","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.contraception.2012.10.018","article-title":"A modified SILCS contraceptive diaphragm for long-term controlled release of the HIV microbicide dapivirine","volume":"88","author":"Major","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.antiviral.2013.09.030_b0235","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2147\/IJWH.S36282","article-title":"Vaginal rings for delivery of HIV microbicides","volume":"4","author":"Malcolm","year":"2012","journal-title":"Int. J. Women\u2019s Health"},{"key":"10.1016\/j.antiviral.2013.09.030_b0240","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.contraception.2013.06.009","article-title":"Delivering on MPTs: addressing the needs, rising to the challenges and making the opportunities","volume":"88","author":"Malcolm","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.antiviral.2013.09.030_b0245","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1093\/humrep\/12.12.2671","article-title":"Levonorgestrel-releasing intrauterine device-wearing women express contraceptive glycodelin A in endometrium during midcycle: another contraceptive mechanism?","volume":"12","author":"Mandelin","year":"1997","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.antiviral.2013.09.030_b0250","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3109\/13625180903427675","article-title":"Efficacy of contraceptive methods: a review of the literature","volume":"15","author":"Mansour","year":"2010","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"key":"10.1016\/j.antiviral.2013.09.030_b0255","unstructured":"Marrazzo, J.M., Ramjee, G., Nair, G., Palanee, T., Mkhize, B., Nakabbiito, C., Taljaard, M., Piper, J., Gomez Feliciano, K., Chirenje, M., 2013. Pre-exposure prophylaxis for HIV in women: daily oral tenofovir, oral tenofovir\/emtricitabine, or vaginal tenofovir gel in the VOICE study (MTN-003). In: 2013 Conference on Retroviruses and Opportunistic Infections, Atlanta, GA."},{"key":"10.1016\/j.antiviral.2013.09.030_b0260","unstructured":"Min, S., DeJesus, E., McCurdy, L., Richmond, G., Torres, J., Ford, S., Chen, S., Lou, Y., Bomar, M., Cyr, T., Fujiwara, T., St. Clair, M., Piscitelli, S., 2009. Pharmacokinetics (PK) and safety in healthy and HIV-infected subjects and short term antiviral efficacy of S\/GSK1265744, a next generation once-daily HIV integrase inhibitor. In: 49th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA."},{"key":"10.1016\/j.antiviral.2013.09.030_b0265","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s10461-012-0248-4","article-title":"Vaginal ring adherence in sub-Saharan Africa: expulsion, removal, and perfect use","volume":"16","author":"Montgomery","year":"2012","journal-title":"AIDS Behav."},{"key":"10.1016\/j.antiviral.2013.09.030_b0270","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1128\/AAC.05662-11","article-title":"Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring","volume":"56","author":"Moss","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.09.030_b0275","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(02)00514-0","article-title":"The combined contraceptive vaginal ring, nuvaring\u00ae: an international study of user acceptability","volume":"67","author":"Nov\u00e1k","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.antiviral.2013.09.030_b0280","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.contraception.2012.06.016","article-title":"An exploratory, randomized, crossover MRI study of microbicide delivery with the SILCS diaphragm compared to a vaginal applicator","volume":"87","author":"Pentlicky","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.antiviral.2013.09.030_b0285","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1086\/345867","article-title":"Herpes simplex virus type 2 infection as a risk factor for human immunodeficiency virus acquisition in men who have sex with men","volume":"187","author":"Renzi","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.09.030_b0290","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1086\/368357","article-title":"Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India","volume":"187","author":"Reynolds","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.09.030_b0295","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.addr.2009.04.022","article-title":"Mirena (levonorgestrel intrauterine system): a successful novel drug delivery option in contraception","volume":"61","author":"Rose","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.antiviral.2013.09.030_b0300","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.bpobgyn.2012.02.001","article-title":"Future strategies in microbicide development","volume":"26","author":"Rosenberg","year":"2012","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.antiviral.2013.09.030_b0305","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0010-7824(90)90103-3","article-title":"The clinical acceptability of a non-medicated vaginal ring","volume":"42","author":"Roumen","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.antiviral.2013.09.030_b0310","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1023\/A:1006748626008","article-title":"Initial UK experience of the levonorgestrel-releasing contraceptive intravaginal ring. Advances in contraception","volume":"15","author":"Sahota","year":"1999","journal-title":"Off. J. Soc. Adv. Contracept."},{"key":"10.1016\/j.antiviral.2013.09.030_b0315","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.contraception.2008.04.118","article-title":"SILCS diaphragm: postcoital testing of a new single-size contraceptive device","volume":"78","author":"Schwartz","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.antiviral.2013.09.030_b0320","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.contraception.2007.02.003","article-title":"Pharmacokinetic study to compare the absorption and tolerability of two doses of levonorgestrel following single vaginal administration of levonorgestrel in Carraguard gel: a new formulation for \u201cdual protection\u201d contraception","volume":"75","author":"Sitruk-Ware","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.antiviral.2013.09.030_b0325","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/S0140-6736(08)61842-5","article-title":"Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Skoler-Karpoff","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2013.09.030_b0330","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1089\/jwh.2007.0529","article-title":"An evaluation of intravaginal rings as a potential HIV prevention device in urban Kenya: behaviors and attitudes that might influence uptake within a high-risk population","volume":"17","author":"Smith","year":"2008","journal-title":"J. Women\u2019s Health"},{"key":"10.1016\/j.antiviral.2013.09.030_b0335","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1311355110","article-title":"Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges","author":"Smith","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2013.09.030_b0340","unstructured":"Spreen, W., Ford, S.L., Chen, S., Gould, E., Wilfret, D., Subich, D., Taishi, T., 2012. Pharmacokinetics, safety, and tolerability of the HIV integrase inhibitor S\/GSK1265744 long acting parenteral nanosuspension following single dose administration to healthy adults. In: 19th International AIDS Conference, Washington, DC."},{"key":"10.1016\/j.antiviral.2013.09.030_b0345","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2147\/IJWH.S27601","article-title":"Potential role of tenofovir vaginal gel for reduction of risk of herpes simplex virus in females","volume":"4","author":"Tan","year":"2012","journal-title":"Int. J. Womens Health"},{"key":"10.1016\/j.antiviral.2013.09.030_b0350","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/095632020701800304","article-title":"In vitro pre- and post-exposure prophylaxis using HIV inhibitors as microbicides against cell-free or cell-associated HIV-1 infection","volume":"18","author":"Terrazas-Aranda","year":"2007","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2013.09.030_b0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/429403","article-title":"Multipurpose prevention technologies: biomedical tools to prevent HIV-1, HSV-2, and unintended pregnancies","volume":"2011","author":"Thurman","year":"2011","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"10.1016\/j.antiviral.2013.09.030_b0360","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1128\/AAC.01529-09","article-title":"Pharmacokinetics and disposition of rilpivirine (tmc278) nanosuspension as a long-acting injectable antiretroviral formulation","volume":"54","author":"van \u2032t Klooster","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.09.030_b0365","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s10461-012-0215-0","article-title":"High acceptability of a vaginal ring intended as a microbicide delivery method for HIV prevention in African women","volume":"16","author":"van der Straten","year":"2012","journal-title":"AIDS Behav."},{"key":"10.1016\/j.antiviral.2013.09.030_b0370","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1128\/AAC.48.1.337-339.2004","article-title":"In vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides","volume":"48","author":"Van Herrewege","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.09.030_b0375","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1089\/aid.2012.0078","article-title":"Antiviral and immunological effects of tenofovir microbicide in vaginal herpes simplex virus 2 infection","volume":"28","author":"Vibholm","year":"2012","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.antiviral.2013.09.030_b0380","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1086\/338231","article-title":"Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis","volume":"185","author":"Wald","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.09.030_b0385","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00007435-199219020-00001","article-title":"Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases","volume":"19","author":"Wasserheit","year":"1992","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.antiviral.2013.09.030_b0390","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v17.i5.30","article-title":"Drug delivery by the intravaginal route","volume":"17","author":"Woolfson","year":"2000","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.antiviral.2013.09.030_b0395","unstructured":"World Health Organization, and the World Bank, 2007. Maternal Mortality in 2005: Estimates developed by WHO, UNICEF, UNFPA, and the World Bank."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213002908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213002908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T18:01:00Z","timestamp":1564596060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354213002908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":79,"alternative-id":["S0166354213002908"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.09.030","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multipurpose prevention technologies: Products in development","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.09.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}